Jim Simons Sensei Biotherapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 211,000 shares of SNSE stock, worth $126,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
211,000
Previous 143,508
47.03%
Holding current value
$126,600
Previous $99,000
124.24%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SNSE
# of Institutions
27Shares Held
2.32MCall Options Held
0Put Options Held
0-
Newtyn Management, LLC New York, NY930KShares$558,1380.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA574KShares$344,3060.0% of portfolio
-
Geode Capital Management, LLC Boston, MA136KShares$81,7900.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX113KShares$67,7400.0% of portfolio
-
Bank Of America Corp Charlotte, NC90.8KShares$54,4570.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $18.4M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...